US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

223.00

-4.7500-2.09%

Pre-market: 225.752.75+1.23%05:36 EDT

Volume:804.93K

Turnover:174.45M

Market Cap:585.26M

PE:- -

High:224.85

Open:221.88

Low:208.28

Close:227.75

52wk High:341.93

52wk Low:102.35

Shares:2.62M

Float Shares:2.62M

Volume Ratio:1.53

T/O Rate:30.67%

Dividend:0.91

Dividend Rate:0.41%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE), Liquidia Technologies (LQDA) and Abbott Laboratories (ABT)

Man Group PLC : Form 8.3 - Spire Healthcare Group Plc

Honliv Healthcare advances probe, control review in push to resume HK trading

Analysts’ Top Healthcare Picks: Regeneron (REGN), Idexx Laboratories (IDXX)

Oneview Healthcare Issues New Tranche of Restricted Share Units

Cullinan Starts FDA Submission for Zipalertinib-Chemotherapy Combo in Non-Small Cell Lung Cancer

MT Newswires Live

Ramsay Health Care Reports Lapse of Performance Rights, Reducing Potential Equity Issuance

What Did The Market Misjudge About Alignment Healthcare?

Simply Wall St.

American Healthcare REIT, Inc. (AHR) Receives a Buy from BMO Capital

Otsuka Unit Taiho Advances Zipalertinib NDA for EGFR Exon 20 NSCLC Under FDA RTOR

Fisher & Paykel Healthcare Adds Shares Under Employee Incentive Plan

Healthcare Stocks Among Top Losers

Press Release: National Healthcare Properties Announces Fourth Quarter 2026 Common Stock Dividend

Sector Update: Healthcare

MT Newswires Live

AbbVie (ABBV) Stock May Be 41% Undervalued On FDA Approval

Simply Wall St.

Wall Street Analysts Are Bullish on Top Healthcare Picks

Sector Update: Healthcare

MT Newswires Live

Favorable FDA Readthrough De-Risks Korro’s KRRO-111; Buy Rating Reaffirmed with Unchanged $21 Price Target

Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Artiva Biotherapeutics, Inc. (ARTV)

Health Care Roundup: Market Talk

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/LABU/news?page=12"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":223,"timestamp":1791489600000,"preClose":227.75,"halted":0,"volume":804929,"hourTrading":{"tag":"盘前","latestPrice":225.75,"preClose":223,"latestTime":"05:36 EDT","volume":422,"amount":94887.0165,"timestamp":1791538593127,"change":2.75,"changeRate":0.012332,"amplitude":0.013659},"delay":0,"changeRate":-0.020856201975850714,"floatShares":2624500,"shares":2624500,"eps":0,"marketStatus":"Pre-Mkt","change":-4.75,"latestTime":"10-09 06:30:16 EDT","open":221.88,"high":224.8479,"low":208.28,"amount":174447835.0605,"amplitude":0.072746,"askPrice":226.4,"askSize":200,"bidPrice":205.78,"bidSize":100,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791552600000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":223,"sharesOutstanding":3074486,"nav":227.52,"aum":597123938.28,"dividendRate":0.0041,"bidAskSpread":0.003146,"preHourTrading":{"tag":"盘前","latestPrice":225.75,"preClose":223,"latestTime":"05:36 EDT","volume":422,"amount":94887.0165,"timestamp":1791538593127,"change":2.75,"changeRate":0.012332,"amplitude":0.013659},"postHourTrading":{"tag":"盘后","latestPrice":223.66,"preClose":223,"latestTime":"19:57 EDT","volume":4124,"amount":918785.7173,"timestamp":1791503872443,"change":0.66,"changeRate":0.00296,"amplitude":0.008427},"volumeRatio":1.526100709509335,"impliedVol":1.0277,"impliedVolPercentile":0.904},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2624500,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.526100709509335,"shares":2624500,"dividePrice":0.9143,"high":224.8479,"amplitude":0.072746,"preClose":227.75,"low":208.28,"week52Low":102.3547,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":223,"committee":-0.333333,"eps":0,"divideRate":0.0041,"volume":804929,"delay":0,"ttmEps":0,"open":221.88,"prevYearClose":159.39,"prevWeekClose":248.72,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":249.65,"twentyDayClose":266,"sixtyDayClose":277.55},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:12,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672715102","title":"Analysts Offer Insights on Healthcare Companies: Wave Life Sciences (WVE), Liquidia Technologies (LQDA) and Abbott Laboratories (ABT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672715102","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672715102?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:51","pubTimestamp":1790934666,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Wave Life Sciences (WVE), Liquidia Technologies (L...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-wave-life-sciences-wve-liquidia-technologies-lqda-and-abbott-laboratories-abt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-wave-life-sciences-wve-liquidia-technologies-lqda-and-abbott-laboratories-abt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","IE00B4R5TH58.HKD","LU0029874061.USD","LU1061106388.HKD","LU0868494617.USD","BK4566","LU0208291251.USD","LU2237957811.SGD","LU0432979614.USD","LU2211815571.USD","SG9999002224.SGD","BK4581","LQDA","BK4592","LU0070302665.USD","WVE","LU1670628061.USD","IE0002141913.USD","LU1721429741.USD","BK4007","IE0009355771.USD","LU1983299246.USD","LU0266013472.USD","SGXZ41872573.SGD","LU0882574055.USD","BK4504","PJP","LU1691799644.USD","LU1670627923.USD","HCSG","LU0122379950.USD","SG9999004303.SGD","LU0211331839.USD","LU2324357040.USD","LU0128526141.USD","LU1914381329.SGD","LU2237957902.USD","IE00BFTCPJ56.SGD","XLV","TMED","LU1023059063.AUD","LU0114720955.EUR","XBI","IHI","LU0289739699.SGD","ABT","LU2089984988.USD","LU1989763427.SGD","LABU","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672716727","title":"Man Group PLC : Form 8.3 - Spire Healthcare Group Plc","url":"https://stock-news.laohu8.com/highlight/detail?id=2672716727","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672716727?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:51","pubTimestamp":1790934660,"startTime":"0","endTime":"0","summary":"FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY INFORMATION (a)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/02/3373672/0/en/man-group-plc-form-8-3-spire-healthcare-group-plc.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","LU0029874061.USD","XLV","BK4585","XBI","BK4588","LU0128526141.USD","HCSG","BK4137","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672715480","title":"Honliv Healthcare advances probe, control review in push to resume HK trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2672715480","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672715480?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:42","pubTimestamp":1790934174,"startTime":"0","endTime":"0","summary":"An update from Honliv Healthcare Management Group Co Ltd ( ($HK:9906) ) is now available. Honliv Healthcare said it continues to work with advisers...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/honliv-healthcare-advances-probe-control-review-in-push-to-resume-hk-trading?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/honliv-healthcare-advances-probe-control-review-in-push-to-resume-hk-trading?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","LU0029874061.USD","BK4588","BK4581","BK4585","LU0128526141.USD","HCSG","LABU","XBI","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672713007","title":"Analysts’ Top Healthcare Picks: Regeneron (REGN), Idexx Laboratories (IDXX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672713007","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672713007?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:20","pubTimestamp":1790932825,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Regeneron (REGN) and Idexx Laboratories (IDXX) with ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-regeneron-regn-idexx-laboratories-idxx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-regeneron-regn-idexx-laboratories-idxx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2362540622.SGD","HCSG","IBB","LU2106854487.HKD","GB00B4LPDJ14.GBP","BK4082","LU0170899867.USD","LU0882574055.USD","LU0823434583.USD","LABU","LU0823416689.USD","LU0289739699.SGD","LU0114720955.EUR","LU0823434740.USD","LU2237438978.USD","XLV","LU1989771016.USD","XBI","LU2468319806.SGD","LU0053666078.USD","BK4567","LU2089984988.USD","LU0345774391.USD","LU1941712348.USD","BK4137","LU1917777945.USD","PAWZ","GB00B4QBRK32.GBP","LU0345774631.USD","LU0690374615.EUR","BK4139","LU0320765992.SGD","LU2324357040.USD","LU1941712264.USD","LU0029874061.USD","LU1974910355.USD","LU2362541273.HKD","IDXX","LU0889565916.HKD","BK4504","BBH","BK4588","LU2404859667.USD","BK4581","REGN","LU0128526141.USD","TBXU","IBBQ","LU2023250504.SGD","LU2404859741.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672771881","title":"Oneview Healthcare Issues New Tranche of Restricted Share Units","url":"https://stock-news.laohu8.com/highlight/detail?id=2672771881","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672771881?lang=en_us&edition=fundamental","pubTime":"2026-10-02 16:17","pubTimestamp":1790929072,"startTime":"0","endTime":"0","summary":"Oneview Healthcare Chess Depository Interests repr 1 ( ($AU:ONE) ) has provided an update. Oneview Healthcare PLC has notified the market of the is...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oneview-healthcare-issues-new-tranche-of-restricted-share-units?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oneview-healthcare-issues-new-tranche-of-restricted-share-units?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","HCSG","XLV","BK4137","LU0029874061.USD","LU0128526141.USD","XBI","BK4588","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672790775","title":"Cullinan Starts FDA Submission for Zipalertinib-Chemotherapy Combo in Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2672790775","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672790775?lang=en_us&edition=fundamental","pubTime":"2026-10-02 16:10","pubTimestamp":1790928630,"startTime":"0","endTime":"0","summary":"Cullinan Therapeutics  has started submitting its new drug application to the US Food and Drug Administration for zipalertinib plus platinum-based chemotherapy in previously untreated non-small cell lung cancer,  the company said late Thursday.The filing is being reviewed under the FDA's Real-Time Oncology Review program, which allows regulators to assess clinical data ahead of a full application.The submission is supported by results from a phase 3 trial showing a significant progression-free survival benefit over chemotherapy alone, the company said.Cullinan expects to complete the regulatory submission by year-end 2026.The company is eligible for milestone payments of $30 million and $100 million tied to potential second-line and first-line approvals, respectively, it said.Cullinan said Zipalertinib remains an investigational drug and has not been approved by any health authority.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4588","BK4139","LABU","CGEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672964227","title":"Ramsay Health Care Reports Lapse of Performance Rights, Reducing Potential Equity Issuance","url":"https://stock-news.laohu8.com/highlight/detail?id=2672964227","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672964227?lang=en_us&edition=fundamental","pubTime":"2026-10-02 10:37","pubTimestamp":1790908670,"startTime":"0","endTime":"0","summary":"Ramsay Health Care ( ($AU:RHC) ) has provided an update. Ramsay Health Care has notified the market of the cessation of a tranche of performance ri...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ramsay-health-care-reports-lapse-of-performance-rights-reducing-potential-equity-issuance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ramsay-health-care-reports-lapse-of-performance-rights-reducing-potential-equity-issuance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EQR","LABU","BK4585","BK4215","REZ","BK4581","XBI","XLV","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672796012","title":"What Did The Market Misjudge About Alignment Healthcare?","url":"https://stock-news.laohu8.com/highlight/detail?id=2672796012","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672796012?lang=en_us&edition=fundamental","pubTime":"2026-10-02 10:24","pubTimestamp":1790907870,"startTime":"0","endTime":"0","summary":"If you backed Alignment Healthcare for its rapid member growth, sub-10% SG&A, and bullish analyst narratives around digital care for seniors, the outcome was harsh. For Alignment Healthcare shareholders, the loss from the start of the year was 61.7%, including dividends. If you had bought on 1 January assuming 34.9% revenue growth, a 3.1% margin, and a 24.2x P/E by 2028, what did that thesis miss about regulatory risk, competition, and now, whistleblower accounting claims?\nNarratives are how...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6034000-choice1-card/1789283981127","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6034000-choice1-card/1789283981127"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-alhc/alignment-healthcare/news/what-did-the-market-misjudge-about-alignment-healthcare","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-alhc/alignment-healthcare/news/what-did-the-market-misjudge-about-alignment-healthcare","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4154","ALHC","BK4588","BK4585","LABU","BK4539","BK4581","XBI","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672933407","title":"American Healthcare REIT, Inc. (AHR) Receives a Buy from BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2672933407","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672933407?lang=en_us&edition=fundamental","pubTime":"2026-10-02 08:36","pubTimestamp":1790901378,"startTime":"0","endTime":"0","summary":"BMO Capital analyst Juan C. Sanabria reiterated a Buy rating on American Healthcare REIT, Inc. today and set a price target of $65.00. According to...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/american-healthcare-reit-inc-ahr-receives-a-buy-from-bmo-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/american-healthcare-reit-inc-ahr-receives-a-buy-from-bmo-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","MDIV","BK4585","LABU","BPRE","BK4588","REIT","AHR","YLDW","XBI","XLV","IQRA","IVRA","RJMG","RNTY","DFRA","BK4225","PSCF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672798115","title":"Otsuka Unit Taiho Advances Zipalertinib NDA for EGFR Exon 20 NSCLC Under FDA RTOR","url":"https://stock-news.laohu8.com/highlight/detail?id=2672798115","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672798115?lang=en_us&edition=fundamental","pubTime":"2026-10-02 07:52","pubTimestamp":1790898737,"startTime":"0","endTime":"0","summary":"The latest update is out from Otsuka Holdings Co ( ($JP:4578) ). Taiho Pharmaceutical, an Otsuka Holdings subsidiary, has begun submitting a New Dr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/otsuka-unit-taiho-advances-zipalertinib-nda-for-egfr-exon-20-nsclc-under-fda-rtor?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/otsuka-unit-taiho-advances-zipalertinib-nda-for-egfr-exon-20-nsclc-under-fda-rtor?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672767746","title":"Fisher & Paykel Healthcare Adds Shares Under Employee Incentive Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2672767746","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672767746?lang=en_us&edition=fundamental","pubTime":"2026-10-02 05:58","pubTimestamp":1790891903,"startTime":"0","endTime":"0","summary":"An announcement from Fisher & Paykel Healthcare Corporation Limited ( ($NZ:FPH) ) is now available. Fisher & Paykel Healthcare Corporation Limited ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fisher-paykel-healthcare-adds-shares-under-employee-incentive-plan-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fisher-paykel-healthcare-adds-shares-under-employee-incentive-plan-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK4585","FPH.NZ","BK4581","XBI","BK8004","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672762292","title":"Healthcare Stocks Among Top Losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2672762292","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672762292?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:55","pubTimestamp":1790888100,"startTime":"0","endTime":"0","summary":"Shares in the healthcare industry fell the most on a modestly positive day for the broader U.S. equities complex.France's Sanofi and Regeneron Pharmaceuticals said they would expand their longstanding alliance to jointly develop and market new immunology medicines, in a deal that could net the U.S. drugmaker up to $8 billion.  The two companies have collaborated for more than two decades. Under the new agreement, Tarrytown, N.Y.-based Regeneron will receive $1 billion upfront from Sanofi and be eligible for additional payments of up to $7 billion subject to development, regulatory and commercial targets, the companies said.Foghorn Therapeutics said it would be slashing nearly half of its workforce after scrapping a drug development partnership with Eli Lilly, forcing the biotech into defensive mode as it attempts to conserve cash.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4585","BK4588","BK4137","LABU","LU0128526141.USD","LU0029874061.USD","XBI","XLV","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672176280","title":"Press Release: National Healthcare Properties Announces Fourth Quarter 2026 Common Stock Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2672176280","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672176280?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:30","pubTimestamp":1790886600,"startTime":"0","endTime":"0","summary":"NEW YORK, Oct. 01, 2026 (GLOBE NEWSWIRE) -- National Healthcare Properties, Inc. (Nasdaq: NHP) (the \"Company\") announced today that its Board of Directors declared a quarterly dividend of $0.075 per s","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CFA.SI","BK4225","BK4588","BK4581","CLR.SI","BK4585","SRT.SI","JJJ.SI","XLV","XBI","GLS.SI","REET","NHP","LABU","SRU.SI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672783761","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2672783761","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672783761?lang=en_us&edition=fundamental","pubTime":"2026-10-02 03:29","pubTimestamp":1790882992,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined late Thursday afternoon, with the NYSE Healthcare Index falling 1% and the State Street Health Care Select Sector SPDR ETF  dropping 1.1%.The iShares Biotechnology ETF  shed 1.6%.In corporate news, Foghorn Therapeutics  and Eli Lilly  have decided not to advance FHD-909 into the clinical development expansion phase after reviewing clinical data from a phase 1 dose escalation trial. Foghorn shares fell 16%, and Lilly was down 0.2%.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0210536198.USD","LU2462591350.SGD","LU2211815571.USD","IE00BJLML261.HKD","LU0432979614.USD","SGXZ31699556.SGD","IE0004445015.USD","IE00BJJMRX11.SGD","LU0943347566.SGD","LU1814569148.SGD","LU2023250504.SGD","SG9999001176.USD","IE00B1XK9C88.USD","LU2023251221.USD","LU0320765059.SGD","LU2264538146.SGD","LU0787776722.HKD","SG9999014880.SGD","LU2237443382.USD","LLII","LU2602419157.SGD","LU2237443549.SGD","IE00BKDWB100.SGD","IE0002141913.USD","LU2168563687.JPY","LU1551013342.USD","JDOC","LU2089984988.USD","LU2236285917.USD","SGXZ51526630.SGD","LU1989771016.USD","LU2552382132.HKD","MHIP","LU1623119135.USD","LU0316494557.USD","FTXH","LU0323591593.USD","LU1868836591.USD","SGXZ99366536.SGD","BK4534","LU2265009873.SGD","BK4599","XBI","LU0256863902.USD","LU2491050071.SGD","LU1868837300.USD","LU2237443465.HKD","BK4588","LU2461242641.AUD","LU0823434740.USD","LLYZ","SG9999018865.SGD","LU1069344957.HKD","LU1720051017.SGD","LU1232071149.USD","TRUH","CURE","IYH","LU1366192091.USD","SG9999017495.SGD","LU0174119429.USD","BK4585","MEDX","LU1983299246.USD","SG9999013999.USD","LU2089284900.SGD","LU0096364046.USD","ELIS","LU2108987350.USD","IE00BFSS7M15.SGD","LU2237438978.USD","LU2271345857.HKD","LU0234572021.USD","LU2357305700.SGD","OZEM","LU2361044865.SGD","LU0672654240.SGD","LU0823434583.USD","LU0058720904.USD","LU2168564065.EUR","LU1093756168.USD","IE00B4R5TH58.HKD","LU1551013425.SGD","IE00BJJMRY28.SGD","LU1917777945.USD","LU2456880835.USD","LU1093756325.SGD","LU2746668461.USD","LU2750360641.GBP","LU2237443978.SGD","PPH","SG9999015986.USD","BK4581","BK4516","IE00B1BXHZ80.USD","IE00BJT1NW94.SGD","BK4533","LU0385154629.USD","LU0114720955.EUR","LU1974910355.USD","LU1629891620.HKD","IE00BFTCPJ56.SGD","LU1720051108.HKD","LU0203201768.USD","LU0353189680.USD","LU1691799644.USD","LU2106854487.HKD","IE0009355771.USD","LU0158827781.USD","LU1064131342.USD","LU2168564495.EUR","LU1868836757.USD","LU0109391861.USD","LU0238689110.USD","LU0882574055.USD","FHTX","VHT","IE00BFSS8Q28.SGD","SG9999014898.SGD","IHE","IE00BN29S564.USD","LU0823416689.USD","LU2491049909.HKD","LU0456855351.SGD","LU2063271972.USD","LU0354030438.USD","LU2750360997.AUD","IE00BK4W5M84.HKD","LU2471134523.USD","LU1057294990.SGD","ELIL","LU2756315664.SGD","LU1979441026.SGD","FHLC","SG9999015978.USD","LU2361045086.USD","LU0820562030.AUD","LU0640476718.USD","LU2023250330.USD","LU2896262040.SGD","LU1267930730.SGD","LU2361044949.HKD","LU2324357040.USD","SG9999014906.USD","LU1291159041.SGD","LU0689472784.USD","LU0158827948.USD","LU2087625088.SGD","LU0198837287.USD","LU0256863811.USD","LU2471134879.HKD","MEDI","LU1127390331.HKD","LU2168564149.EUR","LU0079474960.USD","LU0708995401.HKD","LU1868836914.USD","LU0882574139.USD","LU1023059063.AUD","SG9999001176.SGD","LU2112291526.USD","LU0097036916.USD","LU0006306889.USD","SG9999014914.USD","LU2471134796.USD","LU0683600562.USD","LU0094547139.USD","SG9999018857.SGD","LU0820561909.HKD","WDNA","LU0061475181.USD","LU2360106947.USD","IE00B7KXQ091.USD","LU0345770308.USD","SGXZ57979304.SGD","XLV","LU1280957306.USD","GDOC","LU0225283273.USD","LU0471298777.SGD","LU2491050154.USD","LU0266013472.USD","LU0786609619.USD","IE00B2B36J28.USD","LU2111349929.HKD","GB00BDT5M118.USD","LU2471134952.CNY","LU2746668974.SGD","LU1145028129.USD","LU2237443622.USD","IXJ","LU1988902786.USD","LU1868837136.USD","LU0889565916.HKD","LU2552382058.USD","LU2756315318.SGD","TMED","LU0106261372.USD","LU1712237335.SGD","SG9999015945.SGD","CANC","LU1548497426.USD","LU1323610961.USD","IE00BKPKM429.USD","SG9999015952.SGD","IE0001KFT4U8.USD","LU0320765992.SGD","LU0109394709.USD","IBB","LU2028103732.USD","LU2168564222.USD","RXL","BK4139","LU0353189763.USD","LU2468319806.SGD","LU2237443895.HKD","LU2213496289.HKD","LU0345770993.USD","BK4007","IE0004445239.USD","ILDR","LLYX","LU0122379950.USD","LU0417517546.SGD","LU1035775433.USD","THNR","SGXZ81514606.USD","LU0354030511.USD","IE00BK4W5L77.USD","LLY","LU0289739699.SGD","IE00B4JS1V06.HKD","LU0820561818.USD","LU2552382215.SGD","LU0133085943.USD","PJP","IE0005OL40V9.USD","LABU","LU1061106388.HKD","AGNG","HRTS","LU0466842654.USD","LU0203202063.USD","LU1804176565.USD","LU2417539215.USD","IE00BWXC8680.SGD","LU0471298694.HKD","LU0964807845.USD","IE00B775H168.HKD","LU2089283258.USD","LU2462157665.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672480761","title":"AbbVie (ABBV) Stock May Be 41% Undervalued On FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2672480761","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672480761?lang=en_us&edition=fundamental","pubTime":"2026-10-02 02:21","pubTimestamp":1790878886,"startTime":"0","endTime":"0","summary":"AbbVie’s AbbVie stock has had a strong multiyear run, and with the price recently closing at US$261.59, the key issue is whether that level is backed by the cash the business is expected to generate. Recent drug approvals, partnerships and data readouts all feed into those future cash flows, which is where the valuation debate now sits.\n\nOver the past 5 years AbbVie has delivered a total return of 187.5%, which puts real weight on the question of whether the current share price is fully...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/141885706-card/1789002767761","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/141885706-card/1789002767761"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-abbv/abbvie/news/abbvie-abbv-stock-may-be-41-undervalued-on-fda-approval","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-abbv/abbvie/news/abbvie-abbv-stock-may-be-41-undervalued-on-fda-approval","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ABBV","LU2433249047.HKD","SPHQ","LU2468319806.SGD","LU0726765562.USD","LABU","LU2129689514.USD","LU1929549753.HKD","VHT","LU0256863902.USD","TRUH","LU1720051017.SGD","LU0965508806.USD","JDOC","LU1430594728.SGD","LU1670628061.USD","GLAM","LU1037948541.HKD","PPH","AGNG","LU2089284900.SGD","FHLC","BK4533","BK4139","LU0859254822.USD","LU1670627923.USD","LU2089984988.USD","LU0868494617.USD","LU1989772840.SGD","LU2125909593.SGD","BK4581","LU0114720955.EUR","LU2125909247.SGD","LU0472753341.HKD","LU0689626769.HKD","SG9999011175.SGD","LU2347655073.USD","IYH","RXL","FTXH","XLV","IXJ","LU0795875169.SGD","LU1244550221.USD","DCF","IE00B4R5TH58.HKD","PJP","BK4588","MEDX","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672769775","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2672769775","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672769775?lang=en_us&edition=fundamental","pubTime":"2026-10-02 02:10","pubTimestamp":1790878229,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Satellos Bioscience (MSLE) and Elanco Animal Health ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-367?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-367?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4139","LU0029874061.USD","XBI","BK4588","XLV","MSLE","BK4137","HCSG","LU0128526141.USD","LABU","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672766092","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2672766092","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672766092?lang=en_us&edition=fundamental","pubTime":"2026-10-02 01:12","pubTimestamp":1790874723,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined Thursday afternoon, with the NYSE Healthcare Index falling 1% and the State Street Health Care Select Sector SPDR ETF  dropping 1.1%.The iShares Biotechnology ETF  shed 1.2%.In corporate news, Pfizer  is facing a lawsuit filed by Florida Attorney General James Uthmeier alleging deceptive marketing practices related to COVID-19 vaccines, the attorney general's office said Thursday on X. Pfizer shares were down 1.1%.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2596442595.SGD","IE00BBT3K403.USD","LU0456855351.SGD","SG9999011175.SGD","BK4592","BK4137","BK4585","LU0058720904.USD","LU1066051498.USD","XBI","LU1894683348.USD","SG9999001176.USD","LU0029874061.USD","HCSG","LU0868494617.USD","BK4588","LU0321505439.SGD","SGXZ57979304.SGD","SG9999003800.SGD","BK4581","LU0170899867.USD","SG9999002232.USD","LU0128526141.USD","PFE","LU0306807586.USD","IE0002270589.USD","LU0289739699.SGD","IBB","IE00B19Z3B42.SGD","LU0306806265.USD","LU0225771236.USD","BK4007","BK4533","LU0985481810.HKD","LU1057294990.SGD","BK4599","LABU","LU1894683264.USD","SG9999013999.USD","LU1023059063.AUD","LU0321505868.SGD","XLV","BK4568","LU0225284248.USD","IE00BLSP4452.SGD","LU1883839398.USD","BK4534","LU0234572021.USD","IE00B3T34201.USD","IE000M9KFDE8.USD","IE00BLSP4239.USD","LU0122379950.USD","LU1066053197.SGD","OZEM","BK4550","SG9999002224.SGD","SG9999001176.SGD","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672766733","title":"Favorable FDA Readthrough De-Risks Korro’s KRRO-111; Buy Rating Reaffirmed with Unchanged $21 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2672766733","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672766733?lang=en_us&edition=fundamental","pubTime":"2026-10-02 00:55","pubTimestamp":1790873717,"startTime":"0","endTime":"0","summary":"Analyst from LifeSci Capital maintained a Buy rating on Korro Bio and keeping the price target at $21.00. analyst has given his Buy rating due to a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/favorable-fda-readthrough-de-risks-korros-krro-111-buy-rating-reaffirmed-with-unchanged-21-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/favorable-fda-readthrough-de-risks-korros-krro-111-buy-rating-reaffirmed-with-unchanged-21-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KRRO","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672112766","title":"Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Artiva Biotherapeutics, Inc. (ARTV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672112766","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672112766?lang=en_us&edition=fundamental","pubTime":"2026-10-02 00:40","pubTimestamp":1790872814,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Boston Scientific (BSX) and Artiva Biotherapeutics, ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-boston-scientific-bsx-and-artiva-biotherapeutics-inc-artv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-boston-scientific-bsx-and-artiva-biotherapeutics-inc-artv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2324357040.USD","BK4585","LU0823417737.USD","IE0002141913.USD","LU2362541513.USD","LU0238689110.USD","LU2244417387.USD","LU0122379950.USD","IE00B4R5TH58.HKD","LU1023059063.AUD","LU0432979614.USD","LU1720051017.SGD","LU2506951958.HKD","IE00BJT1NW94.SGD","LU0225283273.USD","LU1720051108.HKD","LU2265009873.SGD","LU2506952170.USD","LU1061106388.HKD","XBI","LU0353189680.USD","SGXZ57979304.SGD","LU1989764748.USD","LABU","LU0823417653.USD","HCSG","IE0009355771.USD","LU1057294990.SGD","LU1291159041.SGD","LU2491050071.SGD","LU0138981039.USD","LU1804176565.USD","LU2491049909.HKD","LU0048584097.USD","SG9999001176.USD","LU0528227936.USD","BK4137","IE00BFTCPJ56.SGD","BK4139","LU0267386448.USD","LU0882574055.USD","LU1366192091.USD","XLV","LU0077335932.USD","ARTV","LU0251132253.USD","LU0345769128.USD","BSX","BK4504","LU0345769631.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672076668","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2672076668","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672076668?lang=en_us&edition=fundamental","pubTime":"2026-10-02 00:20","pubTimestamp":1790871600,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0409 ET - Sanofi's expanded alliance with Regeneron Pharmaceutic","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4585","BK4581","XLV","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":22,"pageCount":12,"totalSize":425,"code":"91000000","status":"200"}]}}